Back

Spironolactone and coronary atherosclerotic plaque modulation: insights from a serial coronary computed tomography angiography cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease (1) Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Junyan Zhang

West China Hospital, Sichuan University, Chengdu (China)

3 More presentations in this session

Presentation thumbnail
ACEi/ARB treatment in patients with myocardial infarction and preserved left ventricular ejection fraction does not confer a benefit: a target trial emulation
Doctor A. Humphreys (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Long-term efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders
Ms L. Saccardi (Stuttgart, DE)
Abstract Slides Video
Presentation thumbnail
Heparin pretreatment in patients with ST-segment elevation myocardial infarction: a meta-analysis
Doctor L. Siega Vignut (Trieste, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in coronary artery disease (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Association of sodium-glucose cotransporter-2 inhibitor with regression of coronary plaque burden
thumbnail
Congress Presentation
Differential effects of glucose-lowering agents on atherosclerotic plaque progression in diabetic patients: a retrospective cohort study using serial coronary CT angiography
thumbnail
Congress Presentation
The impact of statins on calcified plaque burden in patients with non-obstructive coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources